Christopher Peetz - CHIEF EXECUTIVE OFFICER, Director at Mirum Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CHIEF EXECUTIVE OFFICER, Director
Issuer Symbol
MIRM on Nasdaq
All Insider Reports
All Insider Reports

Christopher Peetz - trading volume in the past year for Mirum Pharmaceuticals, Inc.

Holdings reported by Christopher Peetz for Mirum Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 160,294 $16,558,931 $103.30 02 Feb 2026 Direct
Common Stock 187,500 $14,810,625 $78.99 02 Feb 2026 By The Peetz Family Trust
Restricted Stock Units 43,500 $1,198,108 $47.92 28 Jan 2026 Direct Common Stock
Employee Stock Option (right to buy) 150,867 18 Nov 2025 Direct Common Stock
Performance Restricted Stock Units 75,000 28 Jan 2026 Direct Common Stock
Stock Option (right to buy) 67,000 28 Jan 2026 Direct Common Stock

Transactions reported by Christopher Peetz for Mirum Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.